• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Osiris Therapeutics, Inc. (OSIR)

    -NasdaqGM
    18.20 Down 0.16(0.87%) May 22, 4:00PM EDT
    Add to Portfolio
    Prev Close:18.36
    Open:18.39
    Bid:16.50 x 100
    Ask:20.00 x 100
    1y Target Est:23.50
    Beta:0.35
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:17.52 - 18.40
    52wk Range:11.87 - 19.75
    Volume:194,365
    Avg Vol (3m):169,819
    Market Cap:626.04M
    P/E (ttm):650.00
    EPS (ttm):0.03
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OSIRDown 0.87%626.04M
    ABTDown 0.63%72.99B
    BIIBDown 0.62%93.78B

    Key Statistics

    Forward P/E (1 yr):28.00
    P/S (ttm):8.92
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.41
    Quarterly EPS Est (Jun-15) :0.06
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chroni... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback